Home・Elenco Azioni・Novo Nordisk A-S (Class B)

Novo Nordisk A-S (Class B)

Chiusa

256.3 0.23

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

255.65

Massimo

259.75

Metriche Chiave
By Trading Economics
Entrata	-28B 21B
Vendite	-18B 78B
P/E Media del settore	9.483 47.946
EPS	6.18
Rendimento da dividendi	4.74
Margine di Profitto	26.742
Dipendenti	66,700
EBITDA	-31B 39B

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+9.53% upside

Dividendi
By Acuity
Rendimento da dividendi Media del settore	4.74% 2.27%
Utili prossimi	4 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-267B 1.1T
Apertura precedente	256.07
Chiusura precedente	256.3

Novo Nordisk A-S (Class B) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 ott 2026, 23:51 UTC

China's Inflation Rate YoY for September 2026 set to release on October 14, with expectations of a slight increase to 0.1%, amid cautious market sentiment influenced by global economic factors and U.S. Treasury yields.

11 ott 2026, 23:51 UTC

China's PPI data release on October 14, 2026, expected to show a year-on-year increase of 4.5%, amid cautious optimism and potential implications for global inflation and monetary policy.

11 ott 2026, 23:51 UTC

China's inflation rate expected to rise by 0.3% MoM amid cautious market sentiment and global economic pressures ahead of key CPI reports.

11 ott 2026, 23:41 UTC

U.S. Import Prices Report on October 16 Forecasts 0.7% Increase Amid Cautious Market Sentiment and Geopolitical Tensions

11 ott 2026, 23:41 UTC

U.S. Export Prices Expected to Rise 0.01% in September Amid Mixed Economic Sentiment and Cautious Market Optimism

11 ott 2026, 23:31 UTC

Canada's Housing Starts Data Release on October 16 Forecasts Decline to 237.5K Units Amid Cautious Market Sentiment

11 ott 2026, 23:21 UTC

Core Producer Price Index (PPI) for September 2026 set to release on October 15, with a forecasted increase of 0.3%, amid mixed economic sentiment and rising Treasury yields impacting investor optimism.

11 ott 2026, 23:21 UTC

Market Braces for September PPI Release Amid Rising Treasury Yields and Fed Rate Hike Speculation

11 ott 2026, 23:21 UTC

Market Awaits Philadelphia Fed Manufacturing Index Release Amid Mixed Economic Sentiment and Caution Over Inflationary Pressures.

11 ott 2026, 23:21 UTC

Investors Brace for NY Empire State Manufacturing Index Release Amid High Treasury Yields and Inflation Concerns on October 15, 2026.

11 ott 2026, 23:11 UTC

Australia's Full-Time Employment Change Data Set for Release on October 15, Anticipated to Reflect Economic Resilience Amid Global Challenges.

11 ott 2026, 23:11 UTC

Australia's September 2026 unemployment rate forecasted to rise to 4.6%, raising market concerns ahead of the October release amid global economic volatility.

11 ott 2026, 23:11 UTC

Australia's Employment Change Report on October 15 Expected to Show Job Growth Amid Positive Labor Market Sentiment, but Analysts Warn of Potential Volatility.

11 ott 2026, 23:01 UTC

Investors Brace for Volatility Ahead of October 14 CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculations.

11 ott 2026, 23:01 UTC

Core Inflation Rate for September 2026 set to rise by 0.2%, influencing market sentiment and Federal Reserve rate hike expectations ahead of key CPI reports.

11 ott 2026, 23:01 UTC

U.S. CPI Expected to Rise to 336.67 Amid Inflation Concerns and Market Volatility Ahead of October Release

11 ott 2026, 23:01 UTC

Core Inflation Rate YoY for September 2026 set to rise slightly to 2.5%, as markets brace for potential Federal Reserve interest rate hikes amid geopolitical tensions and high Treasury yields.

11 ott 2026, 23:01 UTC

Investors Brace for U.S. CPI Release on October 14, Anticipating Inflation Rise to 3.7% and Potential Fed Policy Shifts

11 ott 2026, 23:01 UTC

U.S. Inflation Rate Expected to Rise 0.6% in September Amidst Market Caution and High Treasury Yields Ahead of Federal Reserve Decisions

11 ott 2026, 23:01 UTC

Macro News

Gold prices are declining amid escalating geopolitical tensions and rising U.S. Treasury yields, remaining below its 20-day moving average.

11 ott 2026, 23:01 UTC

The EUR/NOK is advancing in early trading, influenced by geopolitical tensions and rising yields.

11 ott 2026, 23:01 UTC

The EUR/SEK is trading higher in early trading, rebounding after a slight dip amid rising yields and geopolitical tensions affecting market sentiment.

11 ott 2026, 22:51 UTC

Brazil's Retail Sales MoM data for August 2026, expected to rise by 0.8%, set for release on October 15 amid cautious economic sentiment influenced by global trends.

11 ott 2026, 22:31 UTC

Japan's Machinery Orders MoM data set for October 14, with a modest growth forecast of 0.03% amid cautious market sentiment following recent volatility.

11 ott 2026, 22:31 UTC

RBA Meeting Minutes on October 13 Expected to Address Inflation Concerns and Future Monetary Policy Adjustments.

11 ott 2026, 22:31 UTC

Australia's NAB Business Confidence Report Set for Release Amidst Cautious Market Sentiment and Ongoing Economic Challenges

11 ott 2026, 22:21 UTC

Singapore's Q3 2026 GDP Growth Rate Expected at 0.9%, Amid Cautious Optimism and Input Cost Concerns

11 ott 2026, 22:21 UTC

Mortgage Rates Hit 7.49% Amid Rising Treasury Yields and Inflation Concerns, Sparking Caution in Housing Market Ahead of Upcoming Data Release

11 ott 2026, 22:11 UTC

Brazil's Central Bank to Provide Key Interest Rate Insights Amid Political Turmoil on October 13, 2026.

11 ott 2026, 22:01 UTC

South Korea's September 2026 unemployment rate release on October 15 expected to reveal job market stability amid global inflation concerns.

Confronto tra pari

Modifica del prezzo

Novo Nordisk A-S (Class B) Previsione

Obiettivo di Prezzo

By TipRanks

9.53% in crescita

Previsioni per 12 mesi

Media 1,162.73 DKK 9.53%

Alto 1,550 DKK

Basso 720 DKK

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Novo Nordisk A-S (Class B) - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

11 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 11 che hanno fornito valutazioni azionarie a Novo Nordisk A-S (Class B) - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Novo Nordisk A-S (Class B)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.